Moreover, this study’s emphasis on the clinical relevance of Ki-67, particularly in risk stratification and therapeutic decision-making for aggressive breast cancer subtypes, underscores its significance in personalized medicine [19]. Here, MKI67 is linked to breast carcinoma.